ReproCELL Europe’s PM1 instrument provides real-time information on drug potency by measuring changes in the shape and form of isolated blood vessels during a pre-programmed perfusion schedule.
Wideblue used its product design and engineering expertise to develop a complex system combining ﬂuid handling with digital image capture and analysis. The resulting product embodies Biopta’s patented technology in a self-automated system supported by Wideblue’s custom PC application software.
Wideblue led the development of:
- The ﬂuid handling system
- Optical design of imaging system
- Electronics and ﬂow control ﬁrmware
- Industrial design and human factors
The product was manufactured in low volume for use in a number of preclinical drug development programmes.